| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697820 | Clinical Oncology | 2017 | 7 Pages |
Abstract
As corticosteroids and cyclosporine A are the most common iKS-inducing drugs, their reduction or withdrawal, wherever possible, is needed. Differences in disease severity at presentation between OTR and non-OTR may interfere with the choice of management strategy and the consequent outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
L. Brambilla, A. Tourlaki, G. Genovese,